The potential benefit of PCSK9 inhibitors for NAFLD patients has been suggested; however, future research should focus on PCSK9 inhibitors and their therapeutic role in PCOS and NAFLD patients. This evidence concerns the gene PCSK9 and polycystic ovary syndrome.